You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 255 No. 5, February 7, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (59)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Computed Tomography in Evaluation of Patients With Ovarian Carcinoma in Complete Clinical Remission

Correlation With Surgical-Pathologic Findings

Daniel L. Clarke-Pearson, MD; Lawrence C. Bandy, MD; Michelle Dudzinski, MD; Dennis Heaston, MD; William T. Creasman, MD

JAMA. 1986;255(5):627-630.


Abstract

Computed tomography (CT) of the abdomen and pelvis was performed in 47 patients who were in complete clinical remission from ovarian carcinoma. Results of CT were correlated with surgical-pathologic findings at surgical reexploration. Overall, CT had a sensitivity of 0.32, specificity of 0.77, positive predictive value of 0.79, and negative predictive value of 0.30. Accuracy of CT did not vary by intraperitoneal or retroperitoneal site studied. Computed tomography detected only 7% of tumor nodules 1 cm or less in diameter and only 37% of nodules over 1 cm in diameter. The utility of CT in this clinical setting was limited to approximately 20% of patients with true-positive CT findings who might have been saved surgical reexploration. Due to a high false-negative rate, a normal CT cannot replace a second-look laparotomy for accurate assessment of disease status.

(JAMA 1986;255:627-630)



Author Affiliations

From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology (Drs Clarke-Pearson, Bandy, Dudzinski, and Creasman), and the Department of Radiology (Dr Heaston), Duke University Medical Center, Durham, NC; and the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Illinois at Chicago (Dr Clarke-Pearson).


Footnotes

Reprint requests to Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Illinois at Chicago, 840 S Wood St, Chicago, IL 60612 (Dr Clarke-Pearson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Detection of Residual Subclinical Ovarian Carcinoma after Completion of Adjuvant Chemotherapy
Nouriani et al.
Clin. Cancer Res. 2004;10:2681-2686.
ABSTRACT | FULL TEXT  

Detection of Occult Tumor Using Indium 111-Labeled Anticarcinoembryonic Antigen Antibodies
Halpern et al.
Arch Surg 1992;127:1094-1100.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.